Rosetta Genomics and MediNcrease Health Plans Announce Provider Agreement Expanding Access to RosettaGX™ Reveal and Other Testing Services
PHILADELPHIA, Pennsylvania, REHOVOT, Israel, and ST. PETERSBURG, Florida (October 12, 2017) – Rosetta Genomics Ltd. (NASDAQ: ROSG), a genomic diagnostics company that improves treatment decisions by providing timely and accurate diagnostic information to physicians, and MediNcrease Health Plans, LLC, a national provider network and provider advocacy firm, announce an agreement making the RosettaGX™ Reveal (Reveal), […]